Clinical Trials Directory

Trials / Completed

CompletedNCT03579433

Postmarket Study of an Intraocular Lens Power Selection System

Postmarket Study of ORA With VerifEye+ and Barrett Toric Calculator Used for the Implantation of AcrySof Toric

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
124 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study was to evaluate the visual acuity outcomes when using the Optiwave Refractive Analysis (ORA) with VerifEye+ and Barrett Toric Calculator for calculating intraocular lens (IOL) power and axis in subjects requiring cataract surgery and implanted with a toric IOL in both eyes.

Detailed description

Surgery was done on each eye on different days, 7 to 14 days apart. Subjects were seen for a total of 10 visits with a follow-up duration of 6 months.

Conditions

Interventions

TypeNameDescription
DEVICEORA with VerifEye+Intraoperative device that measures total corneal astigmatism in the aphakic condition and is used for the selection of IOL power. In the pseudophakic condition, ORA provides guidance for the alignment of the toric axis mark.
OTHERAlcon Barrett Toric CalculatorWeb-based software application that utilizes an algorithm (Barrett Formula) to estimate the amount of post-operative corneal astigmatism in order to optimize IOL model selection and axis placement, with interoperative axis alignment done manually.
DEVICEAcrysof® IQ Toric IOLIntraocular lens implanted as a replacement for the cataractous lens during cataract surgery (Model SN6AT3, SN6AT4, Model SN6AT5, Model SN6AT6)

Timeline

Start date
2018-08-16
Primary completion
2019-04-16
Completion
2019-04-16
First posted
2018-07-06
Last updated
2020-04-07
Results posted
2020-04-07

Locations

9 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03579433. Inclusion in this directory is not an endorsement.